🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trials studies how well pembrolizumab and vactosertib work af...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-07-22
Trial ID
NCT03844750
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
The primary objective of the study is to compare sacituzumab tirumotecan co...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Start Date
2023-12-15
Trial ID
NCT06170788
Treatments Being Tested
The purpose was to evaluate the efficacy and safety of the combination of c...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2020-01-22
Trial ID
NCT04139317
Treatments Being Tested
This is a multi-center, open-label phase II study to assess the efficacy of...
Status
Active Not Recruiting
Location
Rutgers Cancer Institute of New Jersey
Start Date
2022-07-26
Trial ID
NCT05404945
Treatments Being Tested
Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2022-08-31
Trial ID
NCT05132504
Treatments Being Tested
Researchers are looking for new ways to treat Limited-Stage Small Cell Lung...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0007)
Start Date
2020-12-08
Trial ID
NCT04624204
This is a study of HB-202/HB-201 alternating 2-vector therapy with pembroli...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06513884
Treatments Being Tested
This is a randomized, double-blind, study that compares pembrolizumab (MK-3...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 1562)
Start Date
2019-04-01
Trial ID
NCT03833167
Treatments Being Tested
The purpose of the study is to test the effects, both good and bad, of the ...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2024-01-12
Trial ID
NCT06109467
Treatments Being Tested